Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hematuria 1Carcinoma, Transitional Cell 1

Interventions

Oxaliplatin 10Endoscopic Mucosal Resection 10Surgical Procedures, Operative 8Standard of Care 8Exercise 7Laparoscopy 6Fluorouracil 6Drug Therapy 6Sodium Chloride 5Leucovorin 5Gastroenterostomy 5Gastrectomy 5Endoscopy, Digestive System 5Saline Solution 4S 1 (combination) 4Preoperative Exercise 4Practice Guidelines as Topic 4Dietary Supplements 4Control Groups 4Biopsy 4Acupuncture Therapy 4Surveys and Questionnaires 3Ropivacaine 3Paclitaxel 3Nutrition Assessment 3Narrow Band Imaging 3Methods 3Indocyanine Green 3Hyperthermic Intraperitoneal Chemotherapy 3Hematologic Tests 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Stomach Neoplasms × Urinalysis × Clear all
NCT00580281 2013-10-24

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Completed
33 enrolled
GastrointestinalMyeloidOther hematologic neoplasm

Leukemia, Stomach Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡